Autism spectrum

National Autism Treatment Provider, Trumpet Behavioral Health, Selects CentralReach For Practice Management Solution and New Client Portal

Retrieved on: 
火曜日, 2月 19, 2019

"CentralReach was the best option for us," commented Trumpet Behavioral Health Chief Clinical Officer, Dr. Amber Valentino.

Key Points: 
  • "CentralReach was the best option for us," commented Trumpet Behavioral Health Chief Clinical Officer, Dr. Amber Valentino.
  • The client portal also gives us the opportunity to empower our families by facilitating conversation and providing visibility around their treatment plan."
  • The CentralReach practice management solution provides customers with a suite of tools to manage the entire back office.
  • Trumpet Behavioral Health offers evidence-based applied behavior analysis (ABA) therapy to children with autism spectrum disorder (ASD) and other developmental disabilities.

Fusion Autism Center Opening 7th ABA Therapy Center in Augusta, Georgia

Retrieved on: 
火曜日, 2月 12, 2019

AUGUSTA, Ga., Feb. 12, 2019 /PRNewswire/ --Fusion Autism Center (FAC) is proud to announce the expansion of their center-based ABA therapy services for children on the autism spectrum.

Key Points: 
  • AUGUSTA, Ga., Feb. 12, 2019 /PRNewswire/ --Fusion Autism Center (FAC) is proud to announce the expansion of their center-based ABA therapy services for children on the autism spectrum.
  • Over 30 years of research has demonstrated the effectiveness of ABA for individuals with autism spectrum disorder (ASD).
  • FAC has an ongoing partnership with the University of Florida that allows the most cutting-edge, data-based ABA research to be implemented immediately across all our center locations.
  • FAC is currently enrolling clients for all Georgia locations, offering private tours, and helping parents navigate through the complex insurance approval process.

As Autism Diagnoses Increase, Shortage of ABA Therapists Remains a Problem; New Government Study Finds 1 in 40 American Children Has Autism

Retrieved on: 
月曜日, 1月 7, 2019

In fact, it is currently used to treat 64 percent of individuals affected by ASD and is considered the gold standard for treatment.

Key Points: 
  • In fact, it is currently used to treat 64 percent of individuals affected by ASD and is considered the gold standard for treatment.
  • ABA, based on the concepts developed by the psychologist B.F. Skinner, is an applied science devoted to developing procedures which will produce observable changes in behavior.
  • The shortage is something Dr. Woolf's team at Butterfly Effects is trying to remedy as more children are receiving ASD diagnoses at younger ages.
  • Autism, Dr. Woolf says, is the only developmental disability where you can lose your diagnosis as a result of treatment.

Children with ADHD or autism could be early indicator for younger siblings, new study finds

Retrieved on: 
月曜日, 12月 10, 2018

According to the findings, younger brothers and sisters of children with ADHD are 13 times more likely to develop ADHD and 4 times more likely to be on the autism spectrum.

Key Points: 
  • According to the findings, younger brothers and sisters of children with ADHD are 13 times more likely to develop ADHD and 4 times more likely to be on the autism spectrum.
  • For children with autism, the likelihood that younger siblings could receive an ADHD diagnosis is 3.5 times higher.
  • This is the first time the recurrence of ADHD has been examined in younger brothers and sisters of children who have been diagnosed with either ADHD or autism, according to Erica Musser , FIU psychologist and study co-author.
  • With this data, researchers were able to determine younger siblings of children with ADHD are at greater risk of developing either ADHD or autism.

Autism Spectrum Disorder (ASD) Pipeline Report 2018: Market Insights, Epidemiology and Market Forecast 2016-2027

Retrieved on: 
水曜日, 12月 5, 2018

The "Autism Spectrum Disorder (ASD) - Market Insights, Epidemiology and Market Forecast-2027" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Autism Spectrum Disorder (ASD) - Market Insights, Epidemiology and Market Forecast-2027" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • Autism Spectrum Disorder (ASD) - Market Insights, Epidemiology and Market Forecast-2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Autism Spectrum Disorder (ASD) in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
  • Autism Spectrum Disorder (ASD) is used to be called as Pervasive Developmental Disorder (PDD).
  • This segment of the Autism Spectrum Disorder (ASD) report encloses the detailed analysis of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.

Neurim Pharmaceuticals Receives Positive CHMP Opinion for Slenyto (Pediatric Prolonged-Release Melatonin) for the Treatment of Insomnia in Children With Autism Spectrum Disorder (ASD)

Retrieved on: 
月曜日, 7月 30, 2018

"The positive CHMP opinion of our PedPRM formulation represents a significant milestone in addressing an unmet need for ASD children who suffer severely from impaired sleep.

Key Points: 
  • "The positive CHMP opinion of our PedPRM formulation represents a significant milestone in addressing an unmet need for ASD children who suffer severely from impaired sleep.
  • Adjusting the dosage according to individual response was easy and the formulation was exceptionally well tolerated in this population.
  • Related measures of children's daytime mood and behaviours also improve with this treatment, as does the parental quality of life.
  • The treatment will address a significant need in the medical management of some children and adolescents with autistic spectrum disorders."

Advisor To Trumpet Behavioral Health Named Next Editor In Chief Of The Journal Of Applied Behavior Analysis

Retrieved on: 
木曜日, 7月 19, 2018

LAKEWOOD, Colo., July 19, 2018 /PRNewswire-PRWeb/ --Trumpet Behavioral Health ("Trumpet") is pleased to announce the appointment of Linda LeBlanc, Ph.D., BCBA-D , to editor in chief of the Journal of Applied Behavior Analysis (JABA).

Key Points: 
  • LAKEWOOD, Colo., July 19, 2018 /PRNewswire-PRWeb/ --Trumpet Behavioral Health ("Trumpet") is pleased to announce the appointment of Linda LeBlanc, Ph.D., BCBA-D , to editor in chief of the Journal of Applied Behavior Analysis (JABA).
  • Dr. LeBlanc's new appointment as editor in chief of this prestigious journal solidifies her place as a well-regarded industry leader in the field of applied behavior analysis.
  • According to Dr. LeBlanc, "I am delighted to have been elected as editor in chief of the Journal of Applied Behavior Analysis.
  • Trumpet Behavioral Health offers evidence-based applied behavior analysis (ABA) therapy to children with autism spectrum disorder (ASD) and other developmental disabilities.

CHOP's Center for Autism Research Shows How the Brain's "Reward Circuit" Plays a Key Role in Symptoms of Autism Spectrum Disorder

Retrieved on: 
月曜日, 6月 18, 2018

This meta-analysis revealed that individuals with ASD process social and nonsocial rewards differently than people not diagnosed with ASD.

Key Points: 
  • This meta-analysis revealed that individuals with ASD process social and nonsocial rewards differently than people not diagnosed with ASD.
  • This meta-analysis complements neuroimaging research published earlier this year by CAR in the journal Molecular Autism.
  • That paper studied the role of the reward system in repetitive behavior and restricted interests, another hallmark behavior of ASD.
  • Funding support for the research in the JAMA Psychiatry paper came from the National Science Foundation Graduate Research Fellowship Program.

Game on For Autism Research Foundation LLC supports scientists working at the frontiers of autism technology research

Retrieved on: 
水曜日, 4月 18, 2018

BOSTON, April 18, 2018 /PRNewswire/ --Today, Game on For Autism Research Foundation LLC (GoFAR) announced its establishment as a new non-profit foundation exclusively dedicated to funding research into technologies designed to help those with autism spectrum disorder (ASD).

Key Points: 
  • BOSTON, April 18, 2018 /PRNewswire/ --Today, Game on For Autism Research Foundation LLC (GoFAR) announced its establishment as a new non-profit foundation exclusively dedicated to funding research into technologies designed to help those with autism spectrum disorder (ASD).
  • For all of the donors, GoFAR is the first foundation led by a minor that they have agreed to support.
  • Struck by this observation, Jamie began to research how games and touchscreen technology could be used to help autistic children communicate.
  • GoFAR Foundation LLC is a 501(c)(3) non-profit charitable organization and a division of The Leslie S. T. Fang Foundation, eligible to receive donations that are tax deductible.